RE:RE:RE:Interesting, PP at 18 cents just announcedMedX like any company looks at opportunities and the costy of opportunities. If a strategic investor wants to put capital into MedX's tresury and that enhance MedX's balance sheet and opens up opportunities to MedX you take the money. You only do this if it speeds up your time to market. I take it that is what is behind this PP. It was done a a premium to the market which is a very good sign.
You have to stop looking at dilution as your benchmark look at the market capitalization as the benchmark it is the more relevant number. MedX could do a 20 to 1 roll-bact and that would solve the shares outstanding issue and I would highly recommend they do that once they have established a meaningful revenue base. MedX is driving to be cash flow positivethis year which is different then debt free as I am sure you are well aware.